What Your Consent Signature Attests

Part of Principal Investigator (PI) Training: Consent as the Investigator's Duty.

About 4 minutes. Free, in your language, no account needed.

Why this matters

At most sites the coordinator conducts the consent discussion, and the investigator signs afterwards. That arrangement is permitted and it is normal. What is not always understood is what the investigator's signature is claiming — and it is a substantive claim, not an acknowledgment of receipt.

The claim being made

Section 2.8.7 and §2.8.8 place a signature on the consent form from the person who conducted the consent discussion, confirming that the information was accurately explained and that consent was freely given. The guideline's Glossary treats a signature — physical or electronic — as an attributable, secure act that expresses agreement or approval.

Where your signature appears on the form as investigator, you are attesting that a proper process happened. Not that a form exists. Not that a signature was collected. That a person was properly informed and freely agreed.

This is why a countersignature applied in a batch, days later, without reference to what actually occurred, is a hollow act. If you cannot say what basis you have for the attestation, you should not be making it.

What "properly informed" means, briefly

The substance is taught in detail in CRLN's GCP course. Four elements decide validity, and removing any one invalidates the consent whatever the paperwork shows:

The three things only you can judge

The coordinator can execute a flawless discussion. Three questions remain medical, and they are the reason your name is on the form.

Was this person capable of deciding, today? Capacity is clinical and it fluctuates. An acutely unwell patient, a person newly given a serious diagnosis, someone on sedating medication — each may be competent in general and not competent this afternoon. Nobody but a clinician should be making that call.

Was the decision genuinely voluntary in this person's circumstances? Voluntariness is contextual. A patient who believes, wrongly, that declining will affect their ongoing care has not freely agreed, and that belief is common and rarely voiced. A patient with no access to the standard treatment outside the trial faces a constrained choice that deserves to be named.

Did they understand what is uncertain? Participants routinely absorb the procedures and miss the science. Someone who can recite the visit schedule but believes they are receiving the better treatment has not understood randomization. That distinction is Module 5's second lesson, and it is the failure mode physicians are best placed to catch.

A defensible practice

You do not need to conduct every consent discussion. You need a basis for the attestation. What that looks like in a busy clinic:

If your involvement is only ever a signature, an inspector will ask what the signature is based on, and there needs to be an answer.

Key takeaways